Where are you?
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Guernsey
  • Ireland
  • Italy
  • Jersey
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Singapore
  • Sweden
  • Switzerland
  • United Kingdom
  • Rest of World
It looks like you’re in
Not your location?
And finally, please confirm the following details
I’m {role} in {country} and I agree to comply with the terms of the website.
You are viewing as from Change

Liontrust India Fund

Q4 2021 review

Past performance does not predict future returns. You may get back less than you originally invested. Reference to specific securities is not intended as a recommendation to purchase or sell any investment.

Over the fourth quarter, the Liontrust India Fund returned -1.9%, versus the MSCI India Index gain of -0.7% and the IA India return of -0.1%*.


The Indian Tax Commissioners have a capital gains regime in place whereby foreign investors are charged a tax on any capital gains on Indian holdings. There is a long term tax rate and when securities are sold, this crystallises the gains which are then taxed. Indian funds typically book a deferred tax liability to cover where a fund has gains and is due to pay this tax. During the quarter there was a change in the Fund’s accounting policy which meant the Fund has also begun to accrue for the capital gains tax due on unrealised capital gains as well as on realised capital gains. This change of policy has meant the fund’s NAV was reduced by 2.5% to reflect this additional accrual.

The final quarter of the year was relatively subdued in terms of overall returns in India, coming at the end of an extremely positive year for the market. The MSCI India Index returned -0.7%, a little ahead of the MSCI Emerging Markets index (-1.6%). Economic growth remains in recovery mode and has proven resilient to returning waves of Covid infections, including the most recent Omicron variant, which has largely been restricted to larger cities and has not caused any major lockdowns. GDP growth came in at 8.4% in the quarter, cementing India’s position as the fastest growing major emerging market economy. This in turn led to ongoing recovery and positive momentum in corporate earnings.

The banking sector in particular has been showing encouraging signs of life, with loan growth picking up impressively, on top of improving asset quality and profitability. We view the re-emergence of a credit cycle (both in terms of availability and demand for credit) as one of the key pillars of the Indian investment story over the coming years – drawing a line under the long period of retrenchment in bank lending, with balance-sheet repair being the key priority across sectors.

The best performing sectors across the period were the IT sector, led by ongoing capex at corporates at both the domestic and multi-national level, industrials – where encouraging signs of positive order flow have been evident – and also consumer discretionary where finally some green shoots have been emerging on the demand side in the auto sector. Elsewhere consumer staples continued to lag due to rising cost pressures and a weaker demand outlook.

The Fund’s positive relative returns were driven, in particular, by strong stock selection in the financials sector –with holdings Indian Energy Exchange and Bajaj Finance enjoying strong returns – and also in industrials where core holding Larsen & Toubro continues to enjoy a robust recovery driven by better underlying operating conditions reflecting in impressive new order flow. Finally, the healthcare sector also provided strong relative returns due to stock picking where a general underweight in large pharmaceutical companies was helpful, whilst the positions in smaller medical equipment and hospital stocks performed much better than the general sector.

On the negative side a pull-back in the previous quarter’s winners in the real estate sector weighed on relative returns, and also the recovery in consumer discretionary stocks, where the Fund has been underweight proved a drag to relative performance.

It was a relatively quiet quarter in terms of Fund activity – though there were three new additions to the portfolio, funded by trimming of positions elsewhere, in particular in the real estate sector where profits from the sizeable gains of the previous quarter were taken. Positions were initiated in Max Healthcare, a hospital operator dominant in India’s National Capital Region, where we see considerable opportunities to improve payer mix as international medical tourism gradually returns and more-profitable tertiary care facilities are expanded. Further positions in Tata Motors – where we see recovery in overall auto demand in general allied to an impressive leadership in the emergent EV sector in India – and KEI Industries, a manufacturer of cables and steel wires and a wholistic beneficiary of rising capex in both the consumption (housing) and corporate (defense and telecommunications) sectors.

India in our view remains exceptionally well placed within the wider emerging market opportunity set, on the cusp of a multi-year investment cycle. After a very strong year, we would recognise that valuations are now relatively extended, which could mute near-term returns, but over the medium-term we think India remains extremely well set and favour the financials sector in particular as a key beneficiary of this investment recovery and especially the large-cap banks which have largely been passed over in the past several quarters.

Discrete years' performance (%)**, to previous quarter-end:







Liontrust India C Acc GBP






MSCI India






IA India/Indian Subcontinent













*Source: FE Analytics as at 31.12.21


**Source: FE Analytics as at 31.12.21. Quartiles were generated on 07.01.22

Understand common financial words and terms See our glossary
Key Risks 
Past performance is not a guide to future performance. The value of an investment and the income generated from it can fall as well as rise and is not guaranteed. You may get back less than you originally invested. The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.
Investment in funds managed by the Global Equity (GE) team may involve investment in smaller companies - these stocks may be less liquid and the price swings greater than those in, for example, larger companies. Investment in funds managed by the GE team may involve foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The team may invest in emerging markets/soft currencies or in financial derivative instruments, both of which may have the effect of increasing volatility. Some of the funds managed by the GE team hold a concentrated portfolio of stocks, meaning that if the price of one of these stocks should move significantly, this may have a notable effect on the value of that portfolio.  


This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID), which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.co.uk or direct from Liontrust. Always research your own investments. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances. 
This should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. The investment being promoted is for units in a fund, not directly in the underlying assets. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, forwarded, reproduced, divulged or otherwise distributed in any form whether by way of fax, email, oral or otherwise, in whole or in part without the express and prior written consent of Liontrust. Always research your own investments and if you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances. 
Global Fundamental

Related commentaries

See all related
Fund updates
Liontrust India Fund Q4 2023 review
icon 23 January 2024
Commentaries Global Equity
Fund updates
Liontrust India Fund Q3 2023 review
icon 17 November 2023
Commentaries Global Equity
Fund updates
Liontrust India Fund Q2 2023 review
icon 24 July 2023
Commentaries Global Equity
Fund updates
Liontrust India Fund Q1 2023 review
icon 25 April 2023
Commentaries Global Equity
Fund updates
Liontrust India Fund Q4 2022 review
icon 30 January 2023
Commentaries Global Equity
Fund updates
Liontrust India Fund Q3 2022 review
icon 24 October 2022
Commentaries Global Equity

How to invest in Liontrust funds

Through a fund platform
Through a financial adviser
Direct with Liontrust